Changes in glucagon-like peptide 1 and 2 levels in people with obesity after a diet-induced weight-loss intervention are related to a specific microbiota signature: A prospective cohort study

Clin Transl Med. 2021 Nov;11(11):e575. doi: 10.1002/ctm2.575.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cohort Studies
  • Female
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide 1 / pharmacology*
  • Glucagon-Like Peptide 1 / therapeutic use
  • Glucagon-Like Peptide 2 / metabolism
  • Glucagon-Like Peptide 2 / pharmacology*
  • Glucagon-Like Peptide 2 / therapeutic use
  • Humans
  • Male
  • Microbiota / drug effects
  • Microbiota / physiology
  • Middle Aged
  • Obesity / diet therapy*
  • Obesity / drug therapy*
  • Prospective Studies
  • Weight Reduction Programs / methods
  • Weight Reduction Programs / standards
  • Weight Reduction Programs / statistics & numerical data

Substances

  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide 1